Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women
Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mulleri...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Shahad F. Obeid [verfasserIn] Bushra F. Hassan [verfasserIn] Taghreed K. Alhaidari [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: مجله كليه طب الكندي - University of Baghdad/ Al-Kindy College of Medicine, 2021, 11(2015), 1 |
|---|---|
| Übergeordnetes Werk: |
volume:11 ; year:2015 ; number:1 |
| Links: |
|---|
| Katalog-ID: |
DOAJ023638478 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ023638478 | ||
| 003 | DE-627 | ||
| 005 | 20230307065641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2015 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ023638478 | ||
| 035 | |a (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Shahad F. Obeid |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. | ||
| 650 | 4 | |a Polycystic ovarian syndrome | |
| 650 | 4 | |a anti-mullerian hormone, | |
| 650 | 4 | |a luteinizing hormone | |
| 650 | 4 | |a follicular stimulating hormone | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Bushra F. Hassan |e verfasserin |4 aut | |
| 700 | 0 | |a Taghreed K. Alhaidari |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t مجله كليه طب الكندي |d University of Baghdad/ Al-Kindy College of Medicine, 2021 |g 11(2015), 1 |w (DE-627)DOAJ078612195 |x 25214365 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2015 |g number:1 |
| 856 | 4 | 0 | |u https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc |z kostenfrei |
| 856 | 4 | 0 | |u https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1810-9543 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2521-4365 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2015 |e 1 | ||
| author_variant |
s f o sfo b f h bfh t k a tka |
|---|---|
| matchkey_str |
article:25214365:2015----::euatmleinomnlvlsmreoplcsioai |
| hierarchy_sort_str |
2015 |
| publishDate |
2015 |
| allfields |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc DE-627 ger DE-627 rakwb eng Shahad F. Obeid verfasserin aut Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R Bushra F. Hassan verfasserin aut Taghreed K. Alhaidari verfasserin aut In مجله كليه طب الكندي University of Baghdad/ Al-Kindy College of Medicine, 2021 11(2015), 1 (DE-627)DOAJ078612195 25214365 nnns volume:11 year:2015 number:1 https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc kostenfrei https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 kostenfrei https://doaj.org/toc/1810-9543 Journal toc kostenfrei https://doaj.org/toc/2521-4365 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 11 2015 1 |
| spelling |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc DE-627 ger DE-627 rakwb eng Shahad F. Obeid verfasserin aut Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R Bushra F. Hassan verfasserin aut Taghreed K. Alhaidari verfasserin aut In مجله كليه طب الكندي University of Baghdad/ Al-Kindy College of Medicine, 2021 11(2015), 1 (DE-627)DOAJ078612195 25214365 nnns volume:11 year:2015 number:1 https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc kostenfrei https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 kostenfrei https://doaj.org/toc/1810-9543 Journal toc kostenfrei https://doaj.org/toc/2521-4365 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 11 2015 1 |
| allfields_unstemmed |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc DE-627 ger DE-627 rakwb eng Shahad F. Obeid verfasserin aut Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R Bushra F. Hassan verfasserin aut Taghreed K. Alhaidari verfasserin aut In مجله كليه طب الكندي University of Baghdad/ Al-Kindy College of Medicine, 2021 11(2015), 1 (DE-627)DOAJ078612195 25214365 nnns volume:11 year:2015 number:1 https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc kostenfrei https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 kostenfrei https://doaj.org/toc/1810-9543 Journal toc kostenfrei https://doaj.org/toc/2521-4365 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 11 2015 1 |
| allfieldsGer |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc DE-627 ger DE-627 rakwb eng Shahad F. Obeid verfasserin aut Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R Bushra F. Hassan verfasserin aut Taghreed K. Alhaidari verfasserin aut In مجله كليه طب الكندي University of Baghdad/ Al-Kindy College of Medicine, 2021 11(2015), 1 (DE-627)DOAJ078612195 25214365 nnns volume:11 year:2015 number:1 https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc kostenfrei https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 kostenfrei https://doaj.org/toc/1810-9543 Journal toc kostenfrei https://doaj.org/toc/2521-4365 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 11 2015 1 |
| allfieldsSound |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc DE-627 ger DE-627 rakwb eng Shahad F. Obeid verfasserin aut Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R Bushra F. Hassan verfasserin aut Taghreed K. Alhaidari verfasserin aut In مجله كليه طب الكندي University of Baghdad/ Al-Kindy College of Medicine, 2021 11(2015), 1 (DE-627)DOAJ078612195 25214365 nnns volume:11 year:2015 number:1 https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc kostenfrei https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 kostenfrei https://doaj.org/toc/1810-9543 Journal toc kostenfrei https://doaj.org/toc/2521-4365 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 11 2015 1 |
| language |
English |
| source |
In مجله كليه طب الكندي 11(2015), 1 volume:11 year:2015 number:1 |
| sourceStr |
In مجله كليه طب الكندي 11(2015), 1 volume:11 year:2015 number:1 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Polycystic ovarian syndrome anti-mullerian hormone, luteinizing hormone follicular stimulating hormone Medicine R |
| isfreeaccess_bool |
true |
| container_title |
مجله كليه طب الكندي |
| authorswithroles_txt_mv |
Shahad F. Obeid @@aut@@ Bushra F. Hassan @@aut@@ Taghreed K. Alhaidari @@aut@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
DOAJ078612195 |
| id |
DOAJ023638478 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ023638478</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307065641.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ023638478</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Shahad F. Obeid</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polycystic ovarian syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-mullerian hormone,</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">luteinizing hormone</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">follicular stimulating hormone</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bushra F. Hassan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Taghreed K. Alhaidari</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">مجله كليه طب الكندي</subfield><subfield code="d">University of Baghdad/ Al-Kindy College of Medicine, 2021</subfield><subfield code="g">11(2015), 1</subfield><subfield code="w">(DE-627)DOAJ078612195</subfield><subfield code="x">25214365</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1810-9543</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2521-4365</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
| author |
Shahad F. Obeid |
| spellingShingle |
Shahad F. Obeid misc Polycystic ovarian syndrome misc anti-mullerian hormone, misc luteinizing hormone misc follicular stimulating hormone misc Medicine misc R Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| authorStr |
Shahad F. Obeid |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)DOAJ078612195 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
25214365 |
| topic_title |
Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women Polycystic ovarian syndrome anti-mullerian hormone luteinizing hormone follicular stimulating hormone |
| topic |
misc Polycystic ovarian syndrome misc anti-mullerian hormone, misc luteinizing hormone misc follicular stimulating hormone misc Medicine misc R |
| topic_unstemmed |
misc Polycystic ovarian syndrome misc anti-mullerian hormone, misc luteinizing hormone misc follicular stimulating hormone misc Medicine misc R |
| topic_browse |
misc Polycystic ovarian syndrome misc anti-mullerian hormone, misc luteinizing hormone misc follicular stimulating hormone misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
مجله كليه طب الكندي |
| hierarchy_parent_id |
DOAJ078612195 |
| hierarchy_top_title |
مجله كليه طب الكندي |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)DOAJ078612195 |
| title |
Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| ctrlnum |
(DE-627)DOAJ023638478 (DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc |
| title_full |
Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| author_sort |
Shahad F. Obeid |
| journal |
مجله كليه طب الكندي |
| journalStr |
مجله كليه طب الكندي |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
txt |
| author_browse |
Shahad F. Obeid Bushra F. Hassan Taghreed K. Alhaidari |
| container_volume |
11 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Shahad F. Obeid |
| author2-role |
verfasserin |
| title_sort |
serum anti-mullerian hormone level as a marker of polycystic ovarian syndrome in iraqi women |
| title_auth |
Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| abstract |
Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. |
| abstractGer |
Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. |
| abstract_unstemmed |
Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
1 |
| title_short |
Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women |
| url |
https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402 https://doaj.org/toc/1810-9543 https://doaj.org/toc/2521-4365 |
| remote_bool |
true |
| author2 |
Bushra F. Hassan Taghreed K. Alhaidari |
| author2Str |
Bushra F. Hassan Taghreed K. Alhaidari |
| ppnlink |
DOAJ078612195 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| up_date |
2024-07-03T18:42:23.581Z |
| _version_ |
1803584424991784960 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ023638478</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307065641.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ023638478</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2179007d56414b3d94104d0b75c3a3bc</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Shahad F. Obeid</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Polycystic ovarian syndrome is one of the common gynaecological diseases encountered nowadays in the gynaecological clinic. Many criteria and diagnostic test had been evolved to be used with different classifications methods.Objectives: The present study aimed to measure the anti-mullerian hormone levels in serum of the women with Polycystic Ovary Syndrome and to test the possibility that if it can be used as a marker for diagnosis of polycystic ovary syndrome patients.Methods: A cross sectional study that had been conductedat Kamal AL-Samaraee Hospital, AL-Suwayrah Hospital andAl-Elwiya Maternity Teaching Hospital during the periodfrom July, 1st, 2013 – Jan. 1st, 2014. Where forty women withPolycystic ovarian syndrome (with mean body mass index of33.25±6.79kg/m2) were enrolled in the study group andbeing compared to apparently health women as a controlgroup that were matched for age and their (mean bodymass index was 27.63±3.51kg/m2). Clinical history,biochemical and hormonal analysis were determined forboth groups.Results: The mean serum of anti-mullerian hormone showed statically significant difference (P = 0.0001) in poly-Cystic ovarian syndrome patients compare to the controlgroup and when this hormone compared with other hormones that use for predicting the occurrence of PCOS as (LH , FSH , testosterone, prolactin and insulin), anti mullarian hormone showed the highest sensitivity and specificity as 82.10 % and 100 % respectively, with a cut off value of (<7.9) in Iraqi women.Conclusions: Anti - mullerian hormone could be the best marker in comparison with other hormones used for the diagnosis of PCOS.Keywords: Polycystic ovarian syndrome, anti-mullerian hormone, luteinizing hormone, follicular stimulating hormone.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polycystic ovarian syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-mullerian hormone,</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">luteinizing hormone</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">follicular stimulating hormone</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bushra F. Hassan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Taghreed K. Alhaidari</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">مجله كليه طب الكندي</subfield><subfield code="d">University of Baghdad/ Al-Kindy College of Medicine, 2021</subfield><subfield code="g">11(2015), 1</subfield><subfield code="w">(DE-627)DOAJ078612195</subfield><subfield code="x">25214365</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2179007d56414b3d94104d0b75c3a3bc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/402</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1810-9543</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2521-4365</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
| score |
7.4002104 |